← Eichor
Study identifier: NCT07507175 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis

Condition: Knee Osteoarthritis  ·  Sponsor: Cairo University

PhaseNA
Planned participants30
Who can joinFemale, 45 Years to 55 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to determine whether gastrocnemius myofascial release is effective in reducing pain and improving physical function in females with knee osteoarthritis. The main question this study aims to answer are: * Does adding gastrocnemius MFR to conventional physical therapy treatment influence pain, physical function, foot posture, and knee disability compared to conventional physical therapy treatment and sham MFR in knee osteoarthritis? * Participants receive gastrocnemius myofascial release treatment or sham gastrocnemius myofascial release treatment for 3 times weekly for 4 weeks for both groups.

This description comes directly from the study's public registry record.

Talk to the study team

Hend Hammam Soliman, Bachelor's Degree  ·  +201008380834  ·  hendhammam18@live.com

Afaf Omar Tahoon  ·  +201119870393  ·  afaf_tahoon@cu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Physical Therapy, Cairo UniversityGiza, Giza Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07507175